Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	58.38K 66.49K 53.74K 50.07K 94.44K 6.32M 96.36K 646K 250K 3.1M 250K 244K 10.8M	P/E 2024	-77.6x	P/E 2025	-87.5x
Enterprise Value	13.17M 15M 12.12M 11.3M 21.3M 1.43B 21.74M 146M 56.49M 700M 56.32M 55.1M 2.44B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	95.95%	Yield 2024 *	-	Yield 2025	-

06-30	Safe Group sharply improves its full-year results
06-29	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-29	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-29	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
12-01	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/07/25	Alert wrongly tagged to Safe SA withdrawn	RE
28/12/24	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
09/09/24	The market burns its idols
06/02/24	Safe: wins its appeal against Neo Medical
28/12/23	Safe: audit initiated for a turnaround plan

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
09/09/24	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
25/11/23	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

06-30	Safe Group améliore nettement ses résultats annuels
05-29	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-29	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group
03-31	SAFE - Forte dynamique de développement au Venezuela
03-16	Evolutions au sein du Conseil d'Administration de SAFE

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	15/02/2010
François-Henri Reynaud DFI	Director of Finance/CFO	-	09/11/2017

Safe Orthopaedics Stock Euronext Paris

Stocks

Medical Equipment, Supplies & Distribution

Valuation: Safe Orthopaedics

Latest news : Safe Orthopaedics

Press Releases: Safe Orthopaedics

News in other languages: Safe Orthopaedics

Quotes and Performance

Managers and Directors: Safe Orthopaedics

Medical Devices & Implants

Financials

Company Profile

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	26/11/2019
Ismaël Nujurally BRD	Director/Board Member	69	26/11/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE ORTHOPAEDICS	-0.79%	-8.36%	-	-	66.49K
STRYKER CORPORATION	+3.86%	+2.55%	-17.27%	+8.78%	120B
SMITH & NEPHEW PLC	+2.92%	-1.70%	+1.95%	-5.73%	12.33B
GLAUKOS CORPORATION	+2.74%	-0.75%	+36.54%	+103.04%	8.08B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-0.64%	+1.67%	-48.31%	-71.81%	4B
DOUBLE MEDICAL TECHNOLOGY INC.	+1.85%	+2.81%	+18.98%	+40.15%	2.57B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-1.23%	+3.87%	-12.07%	-14.48%	1.86B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-0.41%	+1.29%	-5.26%	-25.04%	1.62B
L&C BIO CO.,LTD	-3.31%	-6.90%	+221.83%	+153.84%	1.58B
Average	+0.66%	+4.00%	+24.55%	+23.59%	19.02B
Weighted average by Cap.	+3.44%	+0.21%	-10.39%	+11.88%

	2024	2025
Net sales	5.04M 5.74M 4.64M 4.32M 8.15M 546M 8.32M 55.81M 21.62M 268M 21.56M 21.09M 932M	5.36M 6.11M 4.94M 4.6M 8.68M 581M 8.85M 59.38M 23.01M 285M 22.94M 22.44M 992M
Net income	-1.93B -2.2B -1.78B -1.65B -3.12B -209B -3.18B -21.36B -8.28B -103B -8.25B -8.07B -357B	-4.67M -5.32M -4.3M -4.01M -7.56M -506M -7.71M -51.75M -20.05M -248M -19.99M -19.56M -865M
Net Debt	11.47M 13.06M 10.56M 9.84M 18.56M 1.24B 18.93M 127M 49.2M 610M 49.05M 47.99M 2.12B	13.11M 14.93M 12.07M 11.25M 21.21M 1.42B 21.64M 145M 56.24M 697M 56.07M 54.86M 2.43B